Want to join the conversation?
Biopharmaceutical company $REGN said it is partnering with Bayer to develop a combination therapy of the angiopoietin2 antibody nesvacumab and the VEGF trap aflibercept for the treatment of serious eye diseases. As per the terms, $REGN will receive a $50MM upfront payment and will share global development costs for the program with Bayer.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.